B. Evans

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

Peptide Hormone Cholecystokinin, Medicinal Chemistry, Drug Target +15

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 327 citations · Full text

Peptide Engineering, Peptide Science, Pharmacotherapy +19

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Mark G. Bock, Robert M. DiPardo, B. Evans et al. · Journal of Medicinal Chemistry · 1989 · 309 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Experimental Pharmacology +18

A Novel Benzodiazepine that Activates Cardiac Slow Delayed Rectifier K+ Currents

Joseph J. Salata, Nancy K. Jurkiewicz, Jixin Wang et al. · Molecular Pharmacology · 1998 · 156 citations

A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and .gamma.-(aminoalkyl)-.gamma.-lactones

B. Evans, Kenneth E. Rittle, Carl F. Homnick et al. · The Journal of Organic Chemistry · 1985 · 118 citations

Asymmetric Catalysis, Enantioselective Synthesis, Engineering +12